Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Optimal Sequencing Determination for Relapsed Multiple Myeloma

Multiple Myeloma

Multiple Myeloma
N/A
Sengsayadeth, Salyka
VICCPCL19135

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Multiple Cancer Types

The purpose of this study is to evaluate the safety and tolerability of TAK-169, establish the maximum tolerated dose (MTD) and / or recommended phase 2 dose (RP2D), and to provide a preliminary evaluation of the clinical activity of TAK-169 monotherapy in participants with RRMM.
Multiple Myeloma, Phase I
I
Dholaria, Bhagirathbhai
NCT04017130
VICCHEMP1975

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: